|
|
||||||||


*
Dipartimento di Medicina Sperimentale, Università Magna Graecia di Catanzaro, Catanzaro, Italy;
Department of Pediatric Gastroenterology, St. Bartholomews and the Royal London School of Medicine and Dentistry, London, United Kingdom;
Dipartimento di Pediatria, Università di Napoli Federico II, Naples, Italy; and
§
Dipartimento di Medicina Interna, Università di Roma tor Vergata, Rome, Italy
Crohn s disease (CD) is a chronic intestinal inflammatory
disorder characterized by aberrant mucosal Th1 cell activation and
production of IL-12, the major Th1-driving factor. The T cell response
to IL-12 is dependent on the expression of a specific receptor composed
of two subunits, termed IL-12Rß1 and IL-12Rß2. The content of
IL-12Rß2, as measured at the mRNA level, is crucial in regulating Th1
differentiation. In this study we therefore investigated IL-12Rß2 RNA
transcripts in CD. IL-12Rß2 expression was increased
in active CD as well as Helicobacter pylori
(HP)-associated gastritis and Salmonella colitis
compared with that in inactive CD, ulcerative colitis, noninflammatory
controls, and celiac disease. In contrast, IL-12Rß1 transcripts were
expressed at comparable levels in all samples. In CD, IL-12Rß2
expression strictly correlated with tyrosine phosphorylation of STAT4,
a key component of the IL-12-dependent Th1 polarization. This was
associated with a pronounced expression of IFN-
. Transcripts for
IL-12/p40 were detected in CD, HP-positive, and
Salmonella colitis patients, but not in celiac disease,
indicating that IL-12Rß2 up-regulation occurs only in
IL-12-associated Th1 gastrointestinal diseases. Finally, we showed that
stimulation of lamina propria mononuclear cells with IL-12 enhanced
IL-12Rß2, suggesting that IL-12 regulates IL-12Rß2 expression in
human gastrointestinal mucosa. The data show that the signaling pathway
used by IL-12 to induce Th1 differentiation is increased at the site of
disease in CD, further supporting the view that IL-12/IL-12R signals
contribute to the inflammatory response in this
condition.
This article has been cited by other articles:
![]() |
J. T. O'Malley, R. D. Eri, G. L. Stritesky, A. N. Mathur, H.-C. Chang, H. HogenEsch, M. Srinivasan, and M. H. Kaplan STAT4 Isoforms Differentially Regulate Th1 Cytokine Production and the Severity of Inflammatory Bowel Disease J. Immunol., October 1, 2008; 181(7): 5062 - 5070. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weigmann, H. A. Lehr, G. Yancopoulos, D. Valenzuela, A. Murphy, S. Stevens, J. Schmidt, P. R. Galle, S. Rose-John, and M. F. Neurath The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis J. Exp. Med., September 1, 2008; 205(9): 2099 - 2110. [Abstract] [Full Text] [PDF] |
||||
![]() |
I L Huibregtse, A U van Lent, and S J H van Deventer Immunopathogenesis of IBD: insufficient suppressor function in the gut? Gut, April 1, 2007; 56(4): 584 - 592. [Full Text] [PDF] |
||||
![]() |
M. D. Halpern, J. A. Clark, T. A. Saunders, S. M. Doelle, D. M. Hosseini, A. M. Stagner, and B. Dvorak Reduction of experimental necrotizing enterocolitis with anti-TNF-{alpha} Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G757 - G764. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tortorella, I. Stella, G. Piazzolla, V. Cappiello, O. Simone, A. Pisconti, and S. Antonaci Impaired Interleukin-12-Dependent T-Cell Functions During Aging: Role of Signal Transducer and Activator of Transcription 4 (STAT4) and Suppressor of Cytokine Signaling 3 (SOCS3). J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2006; 61(2): 125 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
E M Coccia, M E Remoli, C Di Giacinto, B Del Zotto, E Giacomini, G Monteleone, and M Boirivant Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease Gut, November 1, 2005; 54(11): 1558 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Matsuoka, N Inoue, T Sato, S Okamoto, T Hisamatsu, Y Kishi, A Sakuraba, O Hitotsumatsu, H Ogata, K Koganei, et al. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease Gut, September 1, 2004; 53(9): 1303 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weigmann, A. Nemetz, C. Becker, J. Schmidt, D. Strand, H. A. Lehr, P. R. Galle, I.-C. Ho, and M. F. Neurath A Critical Regulatory Role of Leucin Zipper Transcription Factor c-Maf in Th1-Mediated Experimental Colitis J. Immunol., September 1, 2004; 173(5): 3446 - 3455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M H Holtmann and M F Neurath T helper cell polarisation in coeliac disease: any (T-)bet ? Gut, August 1, 2004; 53(8): 1065 - 1067. [Full Text] [PDF] |
||||
![]() |
D Berrebi, R Maudinas, J-P Hugot, M Chamaillard, F Chareyre, P De Lagausie, C Yang, P Desreumaux, M Giovannini, J-P Cezard, et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon Gut, June 1, 2003; 52(6): 840 - 846. [Abstract] [Full Text] |
||||
![]() |
G. Monteleone, J. Holloway, V. M. Salvati, S. L.-F. Pender, P. D. Fairclough, N. Croft, and T. T. MacDonald Activated STAT4 and a Functional Role for IL-12 in Human Peyer's Patches J. Immunol., January 1, 2003; 170(1): 300 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Eyles, D. Metcalf, M. J. Grusby, D. J. Hilton, and R. Starr Negative Regulation of Interleukin-12 Signaling by Suppressor of Cytokine Signaling-1 J. Biol. Chem., November 8, 2002; 277(46): 43735 - 43740. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Monteleone, P Vavassori, L Biancone, G Monteleone, and F Pallone Immunoregulation in the gut: success and failures in human disease Gut, May 1, 2002; 50(90003): iii60 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rad, M. Gerhard, R. Lang, M. Schoniger, T. Rosch, W. Schepp, I. Becker, H. Wagner, and C. Prinz The Helicobacter pylori Blood Group Antigen-Binding Adhesin Facilitates Bacterial Colonization and Augments a Nonspecific Immune Response J. Immunol., March 15, 2002; 168(6): 3033 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Bauditz, S Wedel, and H Lochs Thalidomide reduces tumour necrosis factor {alpha} and interleukin 12 production in patients with chronic active Crohn's disease Gut, February 1, 2002; 50(2): 196 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Goncalves, M. Ghaem-Maghami, G. Monteleone, G. Frankel, G. Dougan, D. J. M. Lewis, C. P. Simmons, and T. T. MacDonald Critical Role for Tumor Necrosis Factor Alpha in Controlling the Number of Lumenal Pathogenic Bacteria and Immunopathology in Infectious Colitis Infect. Immun., November 1, 2001; 69(11): 6651 - 6659. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |